Brief Report: Secukinumab Provides Significant and Sustained Inhibition of Joint Structural Damage in a Phase III Study of Active Psoriatic Arthritis (Q40740817)
Jump to navigation
Jump to search
scientific article published on 25 March 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Brief Report: Secukinumab Provides Significant and Sustained Inhibition of Joint Structural Damage in a Phase III Study of Active Psoriatic Arthritis |
scientific article published on 25 March 2016 |
Statements
1 reference
Brief Report: Secukinumab Provides Significant and Sustained Inhibition of Joint Structural Damage in a Phase III Study of Active Psoriatic Arthritis (English)
1 reference
1 reference
Robert B Landewé
1 reference
Philip J Mease
1 reference
Iain B McInnes
1 reference
Luminita Pricop
1 reference
Greg Ligozio
1 reference
Hanno B Richards
1 reference
Shephard Mpofu
1 reference
25 March 2016
1 reference
1 reference
68
1 reference
8
1 reference
1914-1921
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference